Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書目詳細資料
主要作者:	Monayem, Kazi Fahim
其他作者:	Momtaz, Tanisha
格式:	Thesis
語言:	English
出版:	Brac University 2024
主題:	Hepatocellular carcinoma Lenvatinib Sorafenib Demographic analysis Clinical decision making Randomized controlled trials Progression-free survival Liver > Cancer > Treatment. Cancer > Molecular aspects.
在線閱讀:	http://hdl.handle.net/10361/23930

相似書籍

Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
由: Ahmad, Sheikh Shafin
出版: (2021)

Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
由: Shawn, Ibna Hasan
出版: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
由: Shobnam, Sohana
出版: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
由: Paul, Pulock
出版: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
由: Hasan, Amit
出版: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
由: Hoque, Ismoth Ara
出版: (2024)

Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
由: Raju, Md. Ismail
出版: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
由: Rahman, Tasnim
出版: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
由: Hasan, Sakib
出版: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
由: Mirza, Maisa Tasnim
出版: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Karim, Samia Binte
出版: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
由: Bristy, Israt Zerin
出版: (2021)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
由: Oishy, Jannatun Noor
出版: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
由: Rahman, Sanjida
出版: (2024)

Anticancer activity of alangium salvifolium flower in ehrlich ascites carcinoma bearing mice
由: Zahan, Ronok, et al.
出版: (2016)

Exploring the use of Ingenol Mebutate to prevent non-melanoma skin cancer: A review
由: Haque, Fariha
出版: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
由: Abir, Shifaty Nur
出版: (2024)

In vitro antioxidant and anti-neoplastic activities of Ocimum sanctum leaves in Ehrlich Ascites Carcinoma bearing mice
由: Islam, M. Saiful, et al.
出版: (2016)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
由: Hossain, Safa Binte
出版: (2019)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
由: Sakib, Hasibul, et al.
出版: (2024)

Statistics and informatics in molecular cancer research

Immunotherapy in the treatment of renal cancer
由: Shimu, Sumaya
出版: (2022)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
由: Chowdhury, Maisha Mosharrat
出版: (2018)

Multidisciplinary Treatment of Hepatocellular Carcinoma
出版: (2013)

Diagnosis and treatment of non-alcoholic fatty liver disease
由: Haque, Sanjida
出版: (2020)

Cancer risk factors: a critical review
由: Tabassum, Tahsina
出版: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
由: Nawar, Anika
出版: (2019)

A systematic review on the comparison of the safety and efficacy of temozolomide and radiotherapy along with another drug combination in the treatment of glioblastoma multiforme
由: Chowdhury, Shamima Zerin
出版: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
由: Zangmo, Thinley
出版: (2024)

Targeting BRAFV600E in the treatment of CRC
由: Roja, Mashwiyat Samrin
出版: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Flora, Sanzida Alam
出版: (2024)

Role of statins as antagonists of SPARC in gastric cancer
由: Shahmat, Rad
出版: (2019)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
由: Pial, Sazia Afrin
出版: (2018)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
由: Akter, Rabia
出版: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
由: Ginsburg, Ophira M., et al.
出版: (2018)

Epigenetic therapy in cancer
由: Abid, Md. Shadman Ridwan
出版: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
由: Khondokar, Faiza
出版: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
由: Mukti, Roushney Fatima, et al.
出版: (2016)

RIPK pathway, as a potential target, for cancer treatment - a review
由: Jahan, Nusrat
出版: (2024)

Biosimilar in lymphoma treatment
由: Tanisha, Mehrin Haque
出版: (2021)